Mental Health
From the Journals
More than 30 experts question validity of serotonin/depression study
The authors of the review article stand by their conclusion.
Latest News
Limiting social media use in youths brings challenges, benefits
“By limiting their social media time, that resulted in less anxiety, less depression, less FOMO, fewer negative emotions, and greater positive...
Latest News
Agency issues advisory on mental health symptoms of long COVID
This advisory helps to raise awareness, especially among primary care practitioners and clinicians who are often the ones treating patients with...
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
From the Journals
New cannabis laws, higher binge drinking rates linked
States that have not enacted cannabis laws showed consistently lower rates of binge drinking over time among all age groups.
From the Journals
Final USPSTF recommendations on anxiety, depression, suicide risk
The authors of an accompanying editorial note that a positive screen result for anxiety “should be immediately followed with clinical evaluation...
Feature
Tips for addressing uptick in mental health visits: Primary care providers collaborate, innovate
Clinical psychologist recommends primary care providers screen all adult patients for depression and anxiety.
From the Journals
Probiotics an effective adjunct to antidepressants for major depression
When compared with the placebo group, the probiotic group also experienced greater improvements in anxiety symptoms.
Commentary
Are you a physician ... or a vending machine?
We stopped prescribing oxycodone and now people are on gabapentin in the highest doses, diversion is up, and so is its abuse.
From the Journals
Depression drives metabolic syndrome
The association between baseline depression and development of metabolic syndrome was strongest for those with severe depression.
From the Journals
Dramatic rise in hallucinogen use among young adults
While hallucinogen dependence has historically been rare in the U.S. population, it could become more common as use increases.